Neurocrine Biosciences shares owned by Goodman & Company, Investment Counsel
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Goodman & Company, Investment Counsel
from 13F filings
Historical chart of Goodman & Company, Investment Counsel investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Goodman & Company, Investment Counsel consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Neurocrine Biosciences by Goodman & Company, Investment Counsel
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2022-12-31 | $83M | 691k | 119.44 |
| 2022-09-30 | $50M | 475k | 106.21 |
| 2022-06-30 | $7.5M | 77k | 97.48 |
| 2020-06-30 | $26M | 206k | 124.24 |
| 2020-03-31 | $50M | 556k | 89.75 |
| 2019-12-31 | $67M | 638k | 105.47 |
| 2019-09-30 | $47M | 530k | 88.21 |
| 2018-09-30 | $79M | 659k | 120.31 |
| 2018-06-30 | $37M | 387k | 95.59 |
| 2017-12-31 | $4.9M | 64k | 77.27 |
More positions owned by Goodman & Company, Investment Counsel
View all positions for Goodman & Company, Investment Counsel